Importance Neonatal abstinence syndrome, which occurs as a result of in utero opioid
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …

Background Neonatal abstinence syndrome (NAS) includes an array of symptoms impacting
opioid-exposed newborns (OEN) owing to postnatal withdrawal from in utero substance …

Neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure is an
increasing problem. Variability in assessment and treatment of NAS has been attributed to …

Neonatal abstinence syndrome (NAS) refers to a constellation of signs that are present in
some newborn infants resulting from the abrupt cessation of passive transfer of maternal …

Neonatal Abstinence Syndrome | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

In April 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human
Development invited experts to a workshop to address numerous knowledge gaps and to …

The incidence of neonatal abstinence syndrome (NAS) has increased dramatically during
the past 15 years, likely due to an increase in antepartum maternal opiate use. Optimal care …

Background The incidence of the neonatal abstinence syndrome, a drug-withdrawal
syndrome that most commonly occurs after in utero exposure to opioids, is known to have …

Objectives: Identify the etiology and epidemiology of neonatal abstinence syndrome.
Describe the typical presentation, evaluation options, and assessment tools for neonatal …

Neonatal abstinence syndrome refers to the signs and symptoms attributed to the cessation
of prenatal exposure (via placental transfer) to various substances. This Primer focuses on …